Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Aims
- Adaptive immune responses: CD8+ cells
- Adaptive immune responses: CD4+ cells
- Adaptive immune responses: B cells
- Immune response cell interactions
- Lymphocytic choriomeningitis virus (LCMV)
- Aspects of immune escape
- Early effector response - control
- CD8+ T cell memory
- Disadvantaged effector response
- Intermediate response, immunopathology
- Problems with this simple view: CD4 help
- Problems with this simple view: B cells
- Exhaustion: a model
- The 'antigen driven' model
- Programmed cell death in LCMV infection
- Blocking PD-1 activates "exhausted" T cells
- Host virus outcomes in LCMV
- Lessons from LCMV
- Syndrome of acute hepatitis
- Biochemical changes in acute hepatitis
- Acute hepatitis pathogenesis
- HCV global epidemiology
- Hepatitis C virus genome
- Diversity of HCV vs. HIV-1 group M
- Spread of Hepatitis C virus
- Control or persistence of infection
- Immune response and clinical course
- Tree of HCV E2 gene
- Humoral responses and acute control
- T cells play a role in disease
- Host virus outcomes in HCV
- Why do responses fail?
- Implications for a vaccine
- Can T cells protect against HCV infection?
- Inducing an HCV-specific T cell response
- The immunogen
- MHC class I tetrameric complexes
- Tracked population of antivrial T cells
- Summary
Topics Covered
- The roles of adaptive immunity in responses to virus infection
- Methods used to investigate role of T cells in immunity to infection in murine and human systems
- LCMV as a model for antiviral responses and HCV parallels
- Key mechanisms regulating CD8+ T cell responses in chronic infection
- Induction of T cell responses as a possible vaccine strategy
Links
Series:
Categories:
Therapeutic Areas:
External Links
Talk Citation
Klenerman, P. (2020, April 29). Immune responses to viruses [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/XPGP5596.Export Citation (RIS)
Publication History
Financial Disclosures
- There are no commercial/financial matters to disclose.
Other Talks in the Series: The Immune System - Key Concepts and Questions
Transcript
Please wait while the transcript is being prepared...
0:00
My name's Paul Klenerman.
I work in the Nuffield Department of Medicine at the University of Oxford,
and I'm going to talk about the immune responses to viruses.
0:09
The aims of this talk are to overview the roles of
adaptive immunity in responses to virus infection and learn about
some of the methods used to investigate the world of specifically T cells in immunity to
infection using neuron systems and what we've learned from those experimental systems.
Then we're going to look at what happens in studies of human infection.
And hopefully through all of this we'll understand
the key mechanisms that regulate the immune responses to
infection and particularly chronic infections,
of which the most important two are escape and exhaustion.
0:42
In this figure, we're looking at adaptive immune responses to
a virus infection, and the point of this slide is to show
that the different types of immunity are linked together.
So you can see there's a CD8+ T cell,
a CD4+ T cell, and a B cell.
They're all recognising different parts of the virus.
They're using similar tools,
but they're doing it in parallel ways.
So between them they can get a good grip on
what's going on in terms of a virus infection.
So let's start with the CD8+ T cell that has a T cell receptor,
which is recombined to create an enormous amount of diversity.
So the T cell receptors can recognise MHC molecules,
which are illustrated binding a peptide which is bound to
the group of the MHC class I molecule that can be recognised by the T cell.
Now how does that peptide get there?
The virus infects a cell and a protein from the virus is generated.
And like all cellular proteins,
these are then degraded by the proteosome and
small peptides are pushed through the TAP transporter and
loaded in the endoplasmic reticulum onto the class I molecule and pushed
to the surface of the cell as a complex with beta-2 microglobulin.
So the CD8+ T cell in this sense is recognising
proteins from the virus that are present within the cell.
In the middle of the slide,